News
Anal Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Cervical Cancer
Colon Cancer
Esophageal Cancer
Gastric Cancer
GIST
Head & Neck Cancer
Hodgkins Lymphoma
Leukemia
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Liver Cancer
Lung Cancer
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndrome
MPN-PV-ET-MF
Neuroblastoma
Neuroendocrine Tumors
Non Hodgkins Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cancer
Rectal Cancer
Sarcoma
Skin Care
Skin Cancer
Testicular Cancer
Thyroid Cancer
Triple Negative Breast Cancer
Uterine Cancer
About Us
Advertising
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Search
Enhertu (trastuzumab Deruxtecan)
July 26, 2025
Precision Cancer Medicines and Breast Cancer
Charles H. Weaver, MD
April 10, 2025
Tissue Agnostic – Genomic Based Treatment – A Paradigm Shift in Cancer Treatment
Charles H. Weaver, MD
March 30, 2021
Enhertu Treatment of Her2 positive Non-Small Cell Lung Cancer
Charles H. Weaver, MD
January 15, 2021
HER2, Herceptin and Precision Cancer Medicines Targeting Gastric Cancer
Charles H. Weaver, MD
November 13, 2020
Treatment of Stage IV – Metastatic Breast Cancer
Charles H. Weaver, MD
June 2, 2020
Side Effect of Cancer Treatment: Lung Damage (Acute Pulmonary Toxicity)
Charles H. Weaver, MD
February 25, 2020
Esophageal Cancer Survival Improved Using Precision Cancer Medicines
Charles H. Weaver, MD
June 12, 2019
Herceptin Treatment of HER2-positive Advanced-Metastatic Breast Cancer
Charles H. Weaver, MD
September 27, 2018
Treatment of Recurrent Esophageal Cancer
Charles H. Weaver, MD
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website
